1. |
Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks: a compass for global action. J Am Coll Cardiol, 2020, 76(25): 2980-2981.
|
2. |
Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol, 2020, 76(25): 2982-3021.
|
3. |
Luo Y, Xia F, Yu X, et al. Long-term trends and regional variations of hypertension incidence in China: a prospective cohort study from the China health and nutrition survey, 1991-2015. BMJ Open, 2021, 11(1): e042053.
|
4. |
张梅, 吴静, 张笑, 等. 2018年中国成年居民高血压患病与控制状况研究. 中华流行病学杂志, 2021, 42(10): 1780-1789.
|
5. |
Deng X, Hou H, Wang X, et al. Development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in China. Elife, 2021, 10: e66419.
|
6. |
Lim NK, Lee JY, Lee JY, et al. The role of genetic risk score in predicting the risk of hypertension in the Korean population: Korean genome and epidemiology study. PLoS One, 2015, 10(6): e0131603.
|
7. |
Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ, 2015, 350: g7594.
|
8. |
Parikh NI, Pencina MJ, Wang TJ, et al. A risk score for predicting near-term incidence of hypertension: the Framingham heart study. Ann Intern Med, 2008, 148(2): 102-110.
|
9. |
D'Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation, 2008, 117(6): 743-753.
|
10. |
国家卫生计生委. 国家基本公共卫生服务规范(第3版). 北京: 原子能出版社, 2017.
|
11. |
中国高血压防治指南(2018年修订版). 中国心血管杂志, 2019, 24(1): 24-56.
|
12. |
国家卫生和计划生育委员会. 成人体重判定. 2013.
|
13. |
Williams C, Sahagún BE, Su MK. Biostatistics and epidemiology principles for the toxicologist: the "testy" test characteristics part ii: positive predictive value and negative predictive value. J Med Toxicol, 2023, 19(3): 298-302.
|
14. |
Wu J, Li T, Song X, et al. Prevalence and distribution of hypertension and related risk factors in Jilin province, China 2015: a cross-sectional study. BMJ Open, 2018, 8(3): e020126.
|
15. |
Sugiura T, Takase H, Machii M, et al. Central blood pressure predicts the development of hypertension in the general population. Hypertens Res, 2020, 43(11): 1301-1308.
|
16. |
Sun JY, Ma YX, Liu HL, et al. High waist circumference is a risk factor of new-onset hypertension: evidence from the China health and retirement longitudinal study. J Clin Hypertens (Greenwich), 2022, 24(3): 320-328.
|
17. |
Prabhushankar R, Krueger C, Manrique C. Membrane estrogen receptors: their role in blood pressure regulation and cardiovascular disease. Curr Hypertens Rep, 2014, 16(1): 408.
|
18. |
Staessen JA, Ginocchio G, Thijs L, et al. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens, 1997, 11(8): 507-514.
|
19. |
Song L, Shen L, Li H, et al. Age at natural menopause and hypertension among middle-aged and older Chinese women. J Hypertens, 2018, 36(3): 594-600.
|
20. |
Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China hypertension survey, 2012-2015. Circulation, 2018, 137(22): 2344-2356.
|
21. |
Moons KG, Altman DG, Reitsma JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med, 2015, 162(1): W1-W73.
|
22. |
WHO CVD Risk Chart Working Group. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health, 2019, 7(10): e1332-e1345.
|
23. |
Feng Y, Kang K, Xue Q, et al. Value of plasma homocysteine to predict stroke, cardiovascular diseases, and new-onset hypertension: a retrospective cohort study. Medicine (Baltimore), 2020, 99(34): e21541.
|
24. |
Fujii M, Ohnishi H, Saitoh S, et al. The combination of abdominal obesity and high-sensitivity C-reactive protein predicts new-onset hypertension in the general Japanese population: the Tanno-Sobetsu study. Hypertens Res, 2015, 38(6): 426-432.
|
25. |
Feng Y, Yang X, Li Y, et al. Metabolic score for visceral fat: a reliable indicator of visceral obesity for predicting risk for hypertension. Nutrition, 2022, 93: 111443.
|
26. |
李国奇, 刘静, 王薇, 等. 中国35−64岁人群15年高血压发生风险预测研究. 中华高血压杂志, 2014, 22(10): 1000.
|
27. |
吕鸿杰. 原发性高血压发病概率预测模型评价研究. 职业与健康, 2011, 27(18): 2051-2053.
|
28. |
Chen Y, Wang C, Liu Y, et al. Incident hypertension and its prediction model in a prospective northern urban Han Chinese cohort study. J Hum Hypertens, 2016, 30(12): 794-800.
|